United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2549_e56bfe7c-ed11-44ac-a1fd-9299778233f3
- Product NDC
- 71335-2549
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190320
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .025 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-2549-1) · 71335-2549-1
- 90 TABLET in 1 BOTTLE (71335-2549-2) · 71335-2549-2
- 100 TABLET in 1 BOTTLE (71335-2549-3) · 71335-2549-3
- 60 TABLET in 1 BOTTLE (71335-2549-4) · 71335-2549-4
- 28 TABLET in 1 BOTTLE (71335-2549-5) · 71335-2549-5
- 10 TABLET in 1 BOTTLE (71335-2549-6) · 71335-2549-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →